BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 107 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $26,425,000 | -41.3% | 413,665 | -1.7% | 0.01% | -31.2% |
| Q4 2021 | $45,055,000 | -11.0% | 420,646 | -14.6% | 0.02% | -15.8% |
| Q3 2021 | $50,612,000 | +12.6% | 492,287 | -3.7% | 0.02% | +11.8% |
| Q2 2021 | $44,949,000 | -9.4% | 511,021 | +0.1% | 0.02% | -15.0% |
| Q1 2021 | $49,639,000 | -13.3% | 510,533 | -0.0% | 0.02% | -16.7% |
| Q4 2020 | $57,278,000 | +20.9% | 510,716 | -0.1% | 0.02% | +4.3% |
| Q3 2020 | $47,378,000 | +52.1% | 511,091 | +28.7% | 0.02% | +43.8% |
| Q2 2020 | $31,146,000 | +432.1% | 397,024 | +296.7% | 0.02% | +300.0% |
| Q1 2020 | $5,853,000 | -26.8% | 100,083 | -50.0% | 0.00% | 0.0% |
| Q1 2017 | $7,998,000 | +42.6% | 200,000 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $5,610,000 | – | 200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |